anemia

New York based, Keryx Biopharmaceuticals Inc., said a late-stage trial of its experimental drug, Zerenex, for kidney disease met the late-stage trial goal of reducing phosphate levels in blood. The positive results boosted Keryx shares up to 49 percent, selling for $4.80 on Monday’s Nasdaq. Because phosphate levels in blood rise when kidney function declines, […]

Researchers from the Brigham and Women’s Hospital in Boston have discovered a new gene. The Atpif1 gene encourages hemoglobin (the protein in red blood cells that transports oxygen in the blood) production. First study author, Dhvanit Shah, of the hospital’s Division of Hematology, explained that if the body lacks this critical blood cell gene,  red […]